Group 1 - The core viewpoint of the news is that Enhua Pharmaceutical has seen a stock price increase of 5.14%, reaching 25.59 CNY per share, with a total market capitalization of 25.994 billion CNY [1] - Enhua Pharmaceutical, established on March 29, 1999, and listed on July 23, 2008, is primarily engaged in the production, research, and sales of pharmaceuticals [1] - The company's revenue composition includes: anesthetics 54.28%, psychotropic drugs 20.63%, commercial pharmaceuticals 13.08%, neurological drugs 5.51%, raw materials 2.98%, and other sales 2.41% [1] Group 2 - Hengyue Fund holds a significant position in Enhua Pharmaceutical, with its Hengyue Medical Health Selected Mixed A Fund (014220) owning 84,800 shares, accounting for 4.67% of the fund's net value [2] - The fund has achieved a year-to-date return of 38.18% and a one-year return of 45.16%, ranking 899 out of 8178 and 2473 out of 7978 respectively [2] Group 3 - The fund managers of Hengyue Medical Health Selected Mixed A Fund are Song Jialing and Xue Liangchen, with total fund assets of 4.19 billion CNY and 2.41 billion CNY respectively [3] - Song Jialing has a tenure of 1 year and 149 days, achieving a best return of 48.54% during this period [3] - Xue Liangchen has a tenure of 107 days, with a best return of 16.87% during his management [3]

Group 1 - The core point of the article is the announcement by Hengyue Fund Management Co., Ltd. regarding the appointment of Xue Liangchen as a new fund manager for Hengyue Medical Health Selected Mixed Fund (Class A: 014220; Class C: 014221) [1] - Xue Liangchen has a background in investment research, having previously worked at several investment management firms, and joined Hengyue Fund in April 2025 [1] - The Hengyue Medical Health Selected Mixed Fund was established on January 25, 2022, and as of May 21, 2025, it has reported year-to-date returns of 21.64% for Class A and 21.37% for Class C, while the cumulative returns since inception are -30.36% and -31.74%, respectively [1] Group 2 - The cumulative net asset value for Hengyue Medical Health Selected Mixed Fund is reported as 0.6964 yuan for Class A and 0.6826 yuan for Class C [1]